Hassan S
Molecules. 2025; 30(5).
PMID: 40076282
PMC: 11902172.
DOI: 10.3390/molecules30051058.
Debuysschere C, Nekoua M, Hober D
Microorganisms. 2023; 11(5).
PMID: 37317236
PMC: 10220565.
DOI: 10.3390/microorganisms11051262.
Zhu Q
Sci Rep. 2023; 13(1):6310.
PMID: 37072474
PMC: 10113247.
DOI: 10.1038/s41598-023-33585-2.
Wongwiwat W, Fournier B, Bassano I, Bayoumy A, Elgueta Karstegl C, Styles C
J Virol. 2022; 96(12):e0039422.
PMID: 35612313
PMC: 9215254.
DOI: 10.1128/jvi.00394-22.
Zhu Q, Zhao G, Li Y, Talakatta G, Mai H, Le Q
MedComm (2020). 2021; 2(2):175-206.
PMID: 34766141
PMC: 8491203.
DOI: 10.1002/mco2.32.
Epstein-Barr Virus-Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies.
Bauer M, Jasinski-Bergner S, Mandelboim O, Wickenhauser C, Seliger B
Cancers (Basel). 2021; 13(20).
PMID: 34680337
PMC: 8533749.
DOI: 10.3390/cancers13205189.
Epstein-Barr Virus Infection in the Development of Neurological Disorders.
Soldan S, Lieberman P
Drug Discov Today Dis Models. 2021; 32(Pt A):35-52.
PMID: 33897799
PMC: 8059607.
DOI: 10.1016/j.ddmod.2020.01.001.
Targeting Host Cellular Factors as a Strategy of Therapeutic Intervention for Herpesvirus Infections.
Asha K, Sharma-Walia N
Front Cell Infect Microbiol. 2021; 11:603309.
PMID: 33816328
PMC: 8017445.
DOI: 10.3389/fcimb.2021.603309.
Modulation of Endosome Function, Vesicle Trafficking and Autophagy by Human Herpesviruses.
Tognarelli E, Reyes A, Corrales N, Carreno L, Bueno S, Kalergis A
Cells. 2021; 10(3).
PMID: 33806291
PMC: 7999576.
DOI: 10.3390/cells10030542.
Host-virus interaction and viral evasion.
Strumillo S, Kartavykh D, de Carvalho Jr F, Cruz N, de Souza Teodoro A, Diaz R
Cell Biol Int. 2021; 45(6):1124-1147.
PMID: 33533523
PMC: 8014853.
DOI: 10.1002/cbin.11565.
A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infection.
Zhang X, Zhao B, Ding M, Song S, Kang Y, Yu Y
Theranostics. 2020; 10(13):5704-5718.
PMID: 32483413
PMC: 7255000.
DOI: 10.7150/thno.42494.
Alphaherpesvirus gB Homologs Are Targeted to Extracellular Vesicles, but They Differentially Affect MHC Class II Molecules.
Grabowska K, Wachalska M, Graul M, Rychlowski M, Bienkowska-Szewczyk K, Lipinska A
Viruses. 2020; 12(4).
PMID: 32290097
PMC: 7232241.
DOI: 10.3390/v12040429.
Viral Infection of Human Natural Killer Cells.
van Erp E, van Kampen M, van Kasteren P, Wit J
Viruses. 2019; 11(3).
PMID: 30870969
PMC: 6466310.
DOI: 10.3390/v11030243.
Human MHC-II with Shared Epitope Motifs Are Optimal Epstein-Barr Virus Glycoprotein 42 Ligands-Relation to Rheumatoid Arthritis.
Trier N, Izarzugaza J, Chailyan A, Marcatili P, Houen G
Int J Mol Sci. 2018; 19(1).
PMID: 29361739
PMC: 5796260.
DOI: 10.3390/ijms19010317.
A comparative review of viral entry and attachment during large and giant dsDNA virus infections.
Sobhy H
Arch Virol. 2017; 162(12):3567-3585.
PMID: 28866775
PMC: 5671522.
DOI: 10.1007/s00705-017-3497-8.
B-Cell-Rich T-Cell Lymphoma Associated with Epstein-Barr Virus-Reactivation and T-Cell Suppression Following Antithymocyte Globulin Therapy in a Patient with Severe Aplastic Anemia.
Hanaoka N, Murata S, Hosoi H, Shimokado A, Mushino T, Kuriyama K
Hematol Rep. 2015; 7(3):5906.
PMID: 26487932
PMC: 4591498.
DOI: 10.4081/hr.2015.5906.
Effect of high dose vitamin C on Epstein-Barr viral infection.
Mikirova N, Hunninghake R
Med Sci Monit. 2014; 20:725-32.
PMID: 24793092
PMC: 4015650.
DOI: 10.12659/MSM.890423.
Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders.
Martorelli D, Muraro E, Merlo A, Turrini R, Fae D, Rosato A
Clin Dev Immunol. 2012; 2012:931952.
PMID: 22319542
PMC: 3272797.
DOI: 10.1155/2012/931952.
Mapping regions of Epstein-Barr virus (EBV) glycoprotein B (gB) important for fusion function with gH/gL.
Plate A, Reimer J, Jardetzky T, Longnecker R
Virology. 2011; 413(1):26-38.
PMID: 21376360
PMC: 3075949.
DOI: 10.1016/j.virol.2010.12.006.
Progress and problems in understanding and managing primary Epstein-Barr virus infections.
Odumade O, Hogquist K, Balfour Jr H
Clin Microbiol Rev. 2011; 24(1):193-209.
PMID: 21233512
PMC: 3021204.
DOI: 10.1128/CMR.00044-10.
